411 related articles for article (PubMed ID: 28181423)
1. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
3. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
[TBL] [Abstract][Full Text] [Related]
5. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
[TBL] [Abstract][Full Text] [Related]
6. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
Higuchi H; Yamakawa N; Imadome KI; Yahata T; Kotaki R; Ogata J; Kakizaki M; Fujita K; Lu J; Yokoyama K; Okuyama K; Sato A; Takamatsu M; Kurosaki N; Alba SM; Azhim A; Horie R; Watanabe T; Kitamura T; Ando K; Kashiwagi T; Matsui T; Okamoto A; Handa H; Kuroda M; Nakamura N; Kotani A
Blood; 2018 Jun; 131(23):2552-2567. PubMed ID: 29685921
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
8. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.
Nourse JP; Crooks P; Keane C; Nguyen-Van D; Mujaj S; Ross N; Jones K; Vari F; Han E; Trappe R; Fink S; Gandhi MK
J Virol Methods; 2012 Sep; 184(1-2):46-54. PubMed ID: 22609801
[TBL] [Abstract][Full Text] [Related]
10. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
[TBL] [Abstract][Full Text] [Related]
11. EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
Kang D; Skalsky RL; Cullen BR
PLoS Pathog; 2015 Jun; 11(6):e1004979. PubMed ID: 26070070
[TBL] [Abstract][Full Text] [Related]
12. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
13. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
Front Immunol; 2020; 11():367. PubMed ID: 32194570
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
[TBL] [Abstract][Full Text] [Related]
15. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
Qiu J; Cosmopoulos K; Pegtel M; Hopmans E; Murray P; Middeldorp J; Shapiro M; Thorley-Lawson DA
PLoS Pathog; 2011 Aug; 7(8):e1002193. PubMed ID: 21901094
[TBL] [Abstract][Full Text] [Related]
16. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.
Yang HJ; Huang TJ; Yang CF; Peng LX; Liu RY; Yang GD; Chu QQ; Huang JL; Liu N; Huang HB; Zhu ZY; Qian CN; Huang BJ
Virol J; 2013 Oct; 10():314. PubMed ID: 24161012
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.
Cosmopoulos K; Pegtel M; Hawkins J; Moffett H; Novina C; Middeldorp J; Thorley-Lawson DA
J Virol; 2009 Mar; 83(5):2357-67. PubMed ID: 19091858
[TBL] [Abstract][Full Text] [Related]
20. Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.
Navari M; Etebari M; Ibrahimi M; Leoncini L; Piccaluga PP
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]